Wednesday, February 21, 2018

Research Update: Sleep and Dementia

Sleep is an extremely important health-related factor that is often overlooked. Sleep deprivation is known to increase the risk of cardiovascular disease, diabetes and causes irritability, fatigue, and more. However, the risk of developing dementia is also related to sleep. In February 2018, the Journal of the Alzheimer's Association published an article exploring the relationship between sleep and dementia. The research was conducted in the United States, and the study was conducted over a time period of 15 years.

The way that sleep was measured was through polysomnography. Polysomnography is a type of sleep test that uses a device to measure different sleep stages through brain waves, heart rate, temperature, and more. Participants were also asked to describe their sleep patterns and duration to complement the tests. The following conclusions from the study were drawn:

It was found that severe obstructive sleep apnea (OSA) increased the risk of dementia from all causes. Obstructive sleep apnea (OSA) is a condition where the airway becomes completely or partially obstructed during sleep. This condition, characterized by snoring and episodes when the person appears to stop breathing, leads to short periods where there is no air intake, thus the body does not get oxygen. The reasoning behind this may be because OSA can cause cardiovascular problems such as hypertension and atherosclerosis. Hypertension (high blood pressure), and atherosclerosis (plaque build-up in arteries) can both cause dementia by restricting the blood flow to the brain.  

Similar to OSA, sleep duration increased the risk of dementia. Specifically, sleeping less than 7 hours compared to 8-9 hours increased the risk of dementia. While the results of this study were intriguing, the authors of the study explain that more research is needed to further support the claims relating sleep duration and risk of dementia.


Wednesday, February 14, 2018

Ask the Expert: How are people with dementia who have aggressive behaviours treated? Should they be restricted in confined hospital units?

Aggression in patients with Alzheimer's Disease and other dementia occurs in about 10-20% of individuals, but can be more common in the later stages of the disease and can be particularly common in patients who have required placement in a nursing home. There are many "causes" of the aggressive behaviors, including biological, psychological, and environmental causes. Some researchers have focused on "unmet needs" as a cause, while others have taken a more biological approach examining the brain changes (structural and functional, chemical, etc.) that distinguish Alzheimer's patients with aggression from those who are not aggressive.

Treatment of aggression always begins with investigations to determine if there is an obvious cause: a change in their medications, a new medical illness (e.g. infection), pain, a change in the way their caregiver is providing assistance, or a change in the environment (e.g. moving to new home, change in primary caregiver, etc.). Treatment would then start with environmental and behavioral approaches which are often helpful at reducing the behaviors. Medications used to treat aggression should only be used if these non-drug approaches are not good enough, and/or if serious aggression puts the patient, or those in the environment, at risk of imminent and serious physical harm. The reason for this is that many of the drug treatments of aggression are associated with significant side effects, including sedation, falls, stroke, and even death.

To answer the specific question - the hospital is the last place an agitated, aggressive dementia patient should be placed in. Hospitals are noisy, frenetic environments that are not designed to care for patients with dementia, can be terrifying for them, and may make their behavior worse. Avoiding a hospitalization should be a key goal of treatment, which means getting professional help with this behavior earlier, rather than later, is essential.

Professor Nathan Herrmann

Nathan Herrmann MD FRCPC
Professor, Faculty of Medicine, University of Toronto
Lewar Chair in Geriatric Psychiatry
Head, Division of Geriatric Psychiatry
Sunnybrook Health Sciences Centre

Wednesday, February 7, 2018

Ask the Expert: With regards to physician-assisted suicide in Canada, can patients with dementia who are competent to make decisions choose this as an option for the future when the disease significantly worsens?

At the present time, people with dementia would not be eligible for "medical assistance in dying" (the official name for physician assisted suicide) for a number of reasons. First, the person requesting medical assistance in dying must be capable at the time the request for assistance is made, as well as the time the assistance will be administered. This would likely rule out many patients with dementia who might maintain capacity to make the decision early in the disease, but will almost certainly lose capacity as the disease progresses. Secondly, in order to be eligible, the person requesting medical assistance in dying must have a "grievous and irremediable" condition. While Alzheimer's disease and most other dementias would certainly be considered irremediable (in other words irreversible and for the most part untreatable), the term "grievous" would likely not be met. "Grievous" has been defined as "unbearable physical and mental suffering" and for most patients, since insight into their deficits and disabilities is lost early in the disease, there is neither mental, nor physical suffering in dementia.

The process of arranging for medical assistance in dying does vary from province to province, and every case may be different, so it is always worthwhile to discuss future planning with your physician. There are also many alternative care options that can help ease suffering at the end of life and might be preferable to medical assistance in dying. Finally, while the discussion above applies to the current Canadian legislation (which also requires that individuals be at least 18 years of age to request medical assistance in dying), this could change in the future depending on legislation and/or supreme court rulings.  

Professor Nathan Herrmann

Nathan Herrmann MD FRCPC
Professor, Faculty of Medicine, University of Toronto
Lewar Chair in Geriatric Psychiatry
Head, Division of Geriatric Psychiatry
Sunnybrook Health Sciences Centre

Wednesday, January 31, 2018

Research Update: The Challenges of Treating Dementia

With 46.8 million people currently living with dementia and the world’s aging population, there is an urgent need for a treatment to prevent or cure dementia. However, finding a cure for neurodegenerative diseases is very challenging, because these illnesses are hard to diagnose due to the gradual and slow progression of symptoms, as well as the fact that dementia is a complex health problem that can stem from over 50 underlying causes.

Today, most research about potential drug treatments target Alzheimer’s disease, which is the most common form of dementia, accounting for 60 – 70% of all cases. In spite of the high prevalence of Alzheimer’s, we still don’t know enough about the disease’s underlying biology to develop a successful treatment. For instance, it is unknown why the progression of the disease varies between people, or what regulates the toxic build-up of beta-amyloid plaques and tau tangles responsible for Alzheimer’s in the brain. Moreover, patients may have Alzheimer’s disease in addition to other forms of dementia too. Secondly, the blood-brain barrier prevents drugs from reaching the brain through the bloodstream.

Due to these obstacles, some research and clinical trials involving potential dementia drugs have had disappointing results and thus, several companies have stepped away from dementia research. Most recently, pharmaceutical giant Pfizer announced at the beginning of January that it will stop Alzheimer’s research, after costly failed attempts to develop a drug treatment over the past decade.

Nevertheless, there seems to be steps in the right direction for dementia research, as other pharmaceutical companies have continued to test new drugs with modest but promising results. New treatments are targeting the underlying biology of dementia to slow or reverse the disease progression itself. One such approach is called immunotherapy, where antibodies are created to bind to abnormal proteins in the brain – such as the beta-amyloid plaques or tau tangles. These antibodies then expose these abnormal proteins for the body to destroy them.

Non-drug therapies are also being actively investigated – including exercise, focused ultrasound, electrical and magnetic brain stimulation techniques, and cognitive remediation. These techniques, with and without drug therapy, may eventually be shown to be effective at significantly delaying the onset of the disease. Although these may not be “cures”, delaying the onset of Alzheimer’s disease by 5 years can lower the prevalence of the illness by almost 50%.

While it is no easy task to develop a cure for dementia, all dementia research and clinical trials will contribute to our current knowledge of the disease, allowing scientists to create and test new drugs. With perseverance and continued investment in research, we can restore some of what dementia takes away.  


For more information on the challenges and current progress of dementia research, visit https://www.cnn.com/2018/01/18/health/dementia-alzheimers-drug-treatment-partner/index.html

Wednesday, January 24, 2018

Ask the Expert: Do patients with dementia who live with their family members have better outcomes, compared to those who live alone?

This is a really good question, but allow me to broaden the question a bit.

First of all, does living with a spouse or family prevent dementia? The answer is yes - married adults (and likely those living with family) have a reduced risk of developing dementia. Unfortunately, this protection disappears for widows and widowers who actually have a higher risk of dementia. Although the exact reasons for these relationships are unknown, it is likely that marriage and living with someone enriches their environment and increases social interactions and conversation which are mentally stimulating activities, and known to reduce the risk of dementia. On the other hand, grief and bereavement are stressors that are known to have negative effects on health, especially immune function, and therefore may contribute to an increased risk of developing dementia.

Once someone develops dementia, their ability to perform everyday activities inevitably becomes affected. By the time someone has moderately severe dementia, it is impossible for them to live on their own because they will require help with things like food preparation, shopping, grooming and personal hygiene. So, to answer the question, living with a family will definitely allow them to live longer in their own home, as they require more and more help with activities of daily living. This will significantly increase the time before considering moving to an institution like a nursing home is necessary. Living with family also contributes to a richer environment and more mental stimulation, and this may slow the deterioration of the disease.

Professor Nathan Herrmann

Nathan Herrmann MD FRCPC
Professor, Faculty of Medicine, University of Toronto
Lewar Chair in Geriatric Psychiatry
Head, Division of Geriatric Psychiatry
Sunnybrook Health Sciences Centre

Wednesday, January 17, 2018

Research Update: Post-Traumatic Stress Disorder and Dementia

In the January 2018 issue of the Alzheimer’s Association Journal, an article discussed the relationship between Post-traumatic stress disorder (PTSD) and the risk of dementia. The study was conducted in affiliation with the Kaiser Permanente Division of Research in Oakland, California, the Department of Epidemiology and Biostatistics from the University of California, and the Institute for Health & Aging from the University of California. The study examined many potential direct and indirect links between PTSD and dementia outlined below.

Post-traumatic stress disorder or PTSD is a mental health condition that is caused by experiencing or witnessing an extremely traumatic event such as a car crash. People with the condition often suffer from symptoms such as anxiety, flashbacks, shame, and fear.

In American male and female civilians, it was found that PTSD greatly raised the risk for dementia. Older individuals with PTSD were more prone to dementia, whereas younger individuals with PTSD had a lower risk. It was also found that those with PTSD and depression were at even higher risks for developing dementia. These conclusions were drawn from collecting years of data from individuals across the Northern California region.

In American veterans and prisoners of war with PTSD, the risk for developing dementia is also higher. However, the risk was found to be higher in men than women. Although, there are few studies examining the relationship specifically between veterans with PTSD and dementia, thus more research is needed to further investigate.

There are many potential reasons for PTSD causing a higher risk of dementia. One may be due to the stress that PTSD causes. Studies also found that PTSD can decrease gray matter in areas of the brain that are responsible for memory. There may also be a link between PTSD causing a higher risk for illnesses such as stroke, cardiovascular disease, and diabetes, which in turn translate to a higher dementia risk.

This study is very unique as it is the first to investigate the link between PTSD and dementia, and to provide evidence that PTSD does in fact increase the risk of dementia. For more information, visit http://www.alzheimersanddementia.com/article/S1552-5260(17)30221-2/fulltext#ack0010.

Wednesday, December 6, 2017

Ask the Expert: Can dementia pass onto the individual's children and grandchildren?

Yes, but it depends! It depends on what you mean by "dementia". As we have explained in previous blogs, most cases of dementia in people over the age of 65 are caused by Alzheimer's disease. There are 2 types of Alzheimer's disease; "sporadic" Alzheimer's disease and "familial" Alzheimer's disease. The vast majority of cases of Alzheimer's disease are the sporadic type, and having a "first degree relative" (e.g. parent or sibling) with the disease, increases your risk of developing the illness by 2-3 times compared to someone your age that doesn't have a relative with the illness. But "familial" Alzheimer's disease is even worse - if you have a parent with the illness, your risk of developing Alzheimer's disease is 50% . The good news here is that familial Alzheimer's disease is exceedingly rare - only 1-2 % of all cases of Alzheimer's disease. Unfortunately, the risks for other types of dementia, like vascular dementia (dementia due to strokes and cerebrovascular disease) and frontotemporal dementia are also elevated for many family members. While we cannot do anything about our genetics, we can all certainly attempt to lead "brain healthy" lifestyles to delay the onset and reduce the risk of developing dementia as we age.

Professor Nathan Herrmann 

Nathan Herrmann MD FRCPC
Professor, Faculty of Medicine, University of Toronto
Lewar Chair in Geriatric Psychiatry
Head, Division of Geriatric Psychiatry
Sunnybrook Health Sciences Centre